US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ホーム
投資
株式
ドイツ
TG
M1 Kliniken AG (M12) 銘柄情報

M1 Kliniken AG (M12)

18.00

0.12

(0.67%)

終了 6月21日 5:00AM

M1 Kliniken AG (M12) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

18.00

( 0.67% )

買値

17.90

売値

18.08

出来高

366

17.92 日の範囲 18.12

0.00 52 週間の範囲 0.00

時価総額

前日終値

17.88

始値

18.08

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

5,915 €

発行済株式数

18,555,114

配当利回り

1.2 (6.32%)

PER

14.64

1 株当たり利益 (EPS)

1.19

歳入

364.3M

純利益

22.13M

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. It operates through Beauty and Trade segments. The Beauty segment provides aesthetic surgery services, ... M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. It operates through Beauty and Trade segments. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; and medical specialist centers for aesthetic and plastic medicine under the Schlossklinik and M1 Med Beauty names. The Trade segment sells pharmaceuticals and medical products for various therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was incorporated in 2007 and is based in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG. 詳細を表示

セクター

Healthcare

業界

Healthcare Providers & Services

ウェブサイト

www.m1-kliniken.de

本社

Berlin, Germany

設立

2026

M1 Kliniken AG is listed in the Healthcare sector of the Tradegate (DE) with ticker M12. The last closing price for M1 Kliniken was 17.88 €. Over the last year, M1 Kliniken shares have traded in a share price range of 0.00 € to 0.00 €.

M1 Kliniken currently has 18,555,114 shares in issue. The market capitalisation of M1 Kliniken is 333.99 € million. M1 Kliniken has a price to earnings ratio (PE ratio) of 14.64.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

M12 - Frequently Asked Questions (FAQ)

What is the current M1 Kliniken AG share price?

The current share price of M1 Kliniken AG is 18.00 €

How many M1 Kliniken AG shares are in issue?

M1 Kliniken AG has 18,555,114 shares in issue

What is the market cap of M1 Kliniken AG?

The market capitalisation of M1 Kliniken AG is EUR 333.99M

What is the 1 year trading range for M1 Kliniken AG share price?

M1 Kliniken AG has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of M1 Kliniken AG?

The price to earnings ratio of M1 Kliniken AG is 14.64

What is the cash to sales ratio of M1 Kliniken AG?

The cash to sales ratio of M1 Kliniken AG is 0.89

What is the registered address of M1 Kliniken AG?

The registered address for M1 Kliniken AG is Grünauer Straße 5, Berlin, Berlin, 12557

What is the M1 Kliniken AG website address?

The website address for M1 Kliniken AG is www.m1-kliniken.de

Which industry sector does M1 Kliniken AG operate in?

M1 Kliniken AG operates in the Healthcare Providers & Services sector

Forensics888

Forensics888 1分前

And did you read the collusion, as discussed in government emails on how to keep F&F from retaining capital and keeping them from thriving? That is not conservatorship - that is outright theft. And then 100% of net profits, NWS - were funneled from F&F to the treasury. Forgive me for not caring h

FrostyIsland3

FrostyIsland3 2分前

I think timing can still tell us a lot about whether the MHRA issued a 2nd RFI or a CHM Letter to NWBO regarding the DCVax-L MAA. To recap, most people believe that the CHM reviewed DCVax-L for a second time at their meeting on 11/27-28/2025.

"The assessment of your response to the f

The-Shadow

The-Shadow 5分前

https://archive.org/download/Star_Trek_-_The_Next_Generation_-_A_Final_Unity_1994_Spectrum_HoloByte_

https://archive.org/details/FALCONGOLD

TMMI’s SoftVideo Was Commercially Licensed and Used in Major 1990s Multimedia Titles
Independent, published documentation f

stockanalyze

stockanalyze 8分前

what the heck mid terms have to do with it? it has been 18 years and everything is known. didn't pulte said (not sure) that everything is ready to release them when president says so?

SamuiUmi

SamuiUmi 8分前

That's great that you have access to such great tools. Thanks for keeping us filled in all the time on what you seeing. It is much appreciated.

poguemahone

poguemahone 9分前

It’s not just Missling—the entire company (Missling, Boenish, & BOD) are all complicit in this. The fact that only Missling has been fired tells me he was as much the “fall” guy for this shady organization.

This article paints an ugly picture of the company and its motives. Most

HyGro

Clearly able to process -- the issues are pretty simple -- manipulated trial, violating many FDA guidelines -- FDA won't accept it. Pretty simple logic.

stockanalyze

stockanalyze 14分前

when president says 2 corporations that are in conservatorship has market cap of 100x (1T) than what it is now (and multiply even more by 6-14 p/e), you should see a huge uptick even on otc and robinhood. but not, instead it keeps going down. it means market is seeing mnuchin 2.0.

SSKILLZ1

SSKILLZ1 20分前

speaking of guys who are not living up to the expectations. Freddy Peralta what was that his era is now approaching near 5 after that disaster. Than again if it is a move made by the mets GM expect terrible outcomes and you won't be disappointed. I don't think it is possible to be this bad at your j

SeaBlue

SeaBlue 21分前

Thanks for sending that article. I forwarded it to a few folks. Peter Schiff also discussed this in a recent video. I believe Tom Lee is doing something similar with BMNR and ethereum.

Forensics888

Forensics888 23分前

I completely disagree. People have been waiting almost two decades and throwing them $25 for this fraud is obscene. Also the government can give full faith and credit by requiring insurance similar to FDIC insurance for CDs with very strong covenants - not by stealing the shareholder's shares via

WrathToast

WrathToast 29分前

Shiller CAPE = 41.71
This is the second-highest CAPE reading in 145 years of US market history. Only the December 1999 peak (~44) was higher. We are above the 1929 peak (33), above the 2007 peak (27), above the 2021 peak (38). The long-term mean is 17. At today's level, the next decade's rea

my3sons87

my3sons87 30分前

Gamco what is the time frame to conclude the arbitration. Ask perplexity.

Achilles deFlandres

Achilles deFlandres 30分前

Pulte does the job he is given like everyone who works for someone else. Trump made him acting DNI and it should be clear to anybody that DNI takes precednce, especially since the entire authority over F&F conservatorship/stock listing....lies with UST and therefore DJT/Bessent. Right now, the only

ddls

Won't you be glad when Biel is gone, then we can all move on to something else.

Tell the crew it's not about posts, it's about company sales growth. Plus it's not about chit chat talk.

rocketeer357

rocketeer357 33分前

ICCM. Cheap, low float, FDA approved cyro treatment for breast cancer. 15 milllie MKT Cap. Just PR'ed big growth numbers in the USA and popped 200%. Fading back now. Trades on air.

ddls

174-Biel investors of record screwed to the max.

All information expressed today take with a grain of salt.

Investor082

Investor082 39分前

LOL, no one has been stopping NWBO from maximizing revenue, but it’s been disappointing for several years. It ain’t changing for couple more years going forward whether they receive conditional approval or not.

Meanwhile, have fun with the endless dilution in pennies! ;)

againstallodds

againstallodds 54分前

GEMINI AI red flags on SURY:

The probability that SURY (Surya Oil & Gas Corp.) operates primarily as a micro-cap share-selling and dilution vehicle is exceptionally high.

When evaluating OTC entities for share-selling structures, analysts look for specific structural f

MasterBlastr

MasterBlastr 57分前

Thanks - just barely got wet, hopefully get in another tier or two tomorrow.

9Coastal

9Coastal 58分前

The challenge is nil.
No one has to "prove" anything.

Have you already forgotten ..
Past performance does not dictate future performance.

...they actually haven't really had a chance to "actually" perform

They hit a snag. A BIG rift.

fuagf

Wish Henley's star had not crashed and burned. Killed me so musta you too. Sorry about that.

fuagf

fuagf 1時間前

Deeper the better in your case. GL

OMX Helsinki Basic Mater...

iShares Healthcare Innov...

Koninklijke DSM NV

Ingb 3.2003% 15jul29 Ing...

Accelerate Absolute Return

Lindt and Sprungli (PK)

Uniroyal Global Engineer... (EM)

Convertible & Income Sel...

Bounty Oil & Gas

Malayan United Industrie... (EM)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。